APA

Rusconi S., Adorni F., Tau P., Borghi V., Pecorari M., Maserati R., Francisci D., Monno L., Punzi G., Meraviglia P., Paolucci S., Di Biagio A., Bruzzone B., Mancon A., Micheli V. & Zazzi M. (20190429). Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA). : Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Chicago

Rusconi S, Adorni F, Tau P, Borghi V, Pecorari M, Maserati R, Francisci D, Monno L, Punzi G, Meraviglia P, Paolucci S, Di Biagio A, Bruzzone B, Mancon A, Micheli V and Zazzi M. 20190429. Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA). : Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Harvard

Rusconi S., Adorni F., Tau P., Borghi V., Pecorari M., Maserati R., Francisci D., Monno L., Punzi G., Meraviglia P., Paolucci S., Di Biagio A., Bruzzone B., Mancon A., Micheli V. and Zazzi M. (20190429). Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA). : Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

MLA

Rusconi S, Adorni F, Tau P, Borghi V, Pecorari M, Maserati R, Francisci D, Monno L, Punzi G, Meraviglia P, Paolucci S, Di Biagio A, Bruzzone B, Mancon A, Micheli V and Zazzi M. Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA). : Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 20190429.